GUIDESTAR¿ STEERABLE GUIDING SHEATH
Report
- Report Number
- 1035166-2023-00028
- Event Type
- Malfunction
- Date Received
- February 23, 2023
- Date of Event
- February 13, 2023
- Report Date
- August 16, 2023
- Manufacturer
- OSCOR INC.
- Product Code
- DYB
- UDI-DI
- 00885672010911
- PMA / PMN Number
- K140406
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- 003
Narratives
THE DEVICE WAS USED IN THE TREATMENT. NO PRODUCT WAS RETURNED TO OSCOR INC. FOR EVALUATION AS IT WAS DISCARDED; HOWEVER, A COMPLAINT NOTIFICATION WAS PROVIDED. WITHOUT THE RETURN OF THE ACTUAL DEVICE IN QUESTION FOR EVALUATION, OSCOR INC. IS UNABLE TO DETERMINE THE EXACT CAUSE FOR THIS INCIDENT. A REVIEW OF THE MANUFACTURING PROCESSES INDICATES THE PRODUCTION OPERATORS ARE INSTRUCTED TO 100% VISUALLY INSPECT FOR ANY OBVIOUS DEFECT PRIOR TO SHIPMENT. AT THIS TIME, IT IS NOT POSSIBLE TO ASSIGN A DEFINITIVE ROOT CAUSE FOR THE EVENT AS REPORTED. THE COMPLAINT IS NON-VERIFIABLE AS THE PRODUCT WAS NOT RETURNED FOR EVALUATION. NO FURTHER FOLLOW-UP IS REQUIRED. BASED ON THE INVESTIGATION, A CAPA IS NOT REQUIRED AS FINDINGS DID NOT IDENTIFY A DESIGN, LABELING OR MANUFACTURING NON-CONFORMITY. THE RISK REMAINS ACCEPTABLE AND NO NEW FAILURE MODE IDENTIFIED. THE EVENT WILL BE RE-EVALUATED IF ADDITIONAL INFORMATION BECOMES AVAILABLE. OSCOR WILL CONTINUE TO MONITOR THIS EVENT TYPE AND RISK. OSCOR INC. IS SUBMITTING THE ABOVE REPORT TO COMPLY WITH 21 CFR PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THE REPORT IS BASED UPON INFORMATION OBTAINED BY OSCOR INC. WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY FDA. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE, OSCOR INC., OR ITS EMPLOYEES, CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THIS REPORT. NOR DOES THIS REPORT REFLECT A CONCLUSION BY FDA, OSCOR INC., OR ITS EMPLOYEES, THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE DEVICE, OSCOR INC., OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THIS REPORT.
CONCLUSION NOT YET AVAILABLE, EVALUATION IN PROCESS. A FOLLOW-UP WILL BE SUBMITTED AS SOON AS THE INVESTIGATION IS COMPLETE. OSCOR INC. IS SUBMITTING THE ABOVE REPORT TO COMPLY WITH 21 CFR PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THE REPORT IS BASED UPON INFORMATION OBTAINED BY OSCOR INC. WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY FDA. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION THAT THE DEVICE, OSCOR INC., OR ITS EMPLOYEES, CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THIS REPORT. NOR DOES THIS REPORT REFLECT A CONCLUSION BY FDA, OSCOR INC., OR ITS EMPLOYEES, THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE DEVICE, OSCOR INC., OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THIS REPORT.
ADDITIONAL INFORMATION: DURING ATRIAL FIBRILLATION ABLATION, WHILE PULLING THE SHEATH OUT OF THE PATIENT'S LEFT ATRIUM, ASPIRATION OF AIR BUBBLES OCCURRED. THE PATIENT DID NOT EXPERIENCE AN AIR EMBOLISM, AND THERE WAS NO HARM TO THE PATIENT. NO MEDICAL INTERVENTION OR ADDITIONAL SURGICAL PROCEDURE WAS REQUIRED, HOWEVER, THERE WAS A PROCEDURE DELAY OF LESS THAN 30 MINUTES. THE PROCEDURE WAS COMPLETED SUCCESSFULLY USING A COMPETITOR'S SHEATH AND CATHETER. NO FORCE WAS APPLIED, AND PATIENT'S ANATOMY WAS NORMAL. NO PICTURES ARE AVAILABLE. THE DEVICE WILL NOT BE RETURNED, AS IT WAS DISCARDED.
ASPIRATION OF MANY AIR BUBBLES WHILE SHEATH IS IN THE LEFT ATRIUM. NO PATIENT CONSEQUENCES.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 449328 | GUIDESTAR¿ STEERABLE GUIDING SHEATH | INTRODUCER, CATHETER | DYB | OSCOR INC. | D141103 | DP-15916 | 00885672010911 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |